Bargain Hunters: These 3 High-Yielding Stocks Recently Hit New 52-Week Lows

Article highlights dividend opportunities as three stocks hit fresh 52-week lows: Sanofi down 12% YTD to just under $41 (5.7% dividend yield; ~19x trailing earnings) despite Q1 revenue up ~14% at constant FX to €10.5B and Dupixent revenue up ~31% Y/Y, though investors fret about U.S. Dupixent patent expiry in 2031. AT&T is down ~17% YTD to new lows with ~5.3% yield and trades at ~7x P/E, with concerns tied to competitive pressure from SpaceX/Starlink. Vici Properties offers the highest yield here at 6.7% while FFO per share rose to $0.82 in the quarter ended March (vs. $0.51 a year ago) versus an implied quarterly dividend of $0.45, with shares trading at ~9x trailing earnings.

Analysis

This is less a stock-picking catalyst than a rate-sensitive income screen. In the near term, the main flow is likely retail yield-chasing into names that already screen cheap; that can support share prices, but it does not change underlying growth. The highest-quality setup is SNY, where a strong asset base can keep cash flow compounding long enough to outrun the patent-cliff narrative, while T and VICI are more dependent on an eventual easing in discount rates than on any step-change in fundamentals.

Second-order, the real winner from this kind of article is the "yield premium" trade: if 10Y yields drift lower, these equities can re-rate faster than their earnings growth would imply, especially VICI and T. But if rates stay sticky, the market will keep treating them as equity-duration substitutes, and the dividend alone will not prevent multiple compression. For VICI specifically, watch tenant credit and acquisition cap rates; for T, any credible fixed-wireless or satellite-mobile pressure matters more through pricing power than subscriber losses.

Contrarian view: the market may be correctly discounting that high current yield often signals low reinvestment optionality. SNY looks like the only one with a meaningful fundamental bridge between today’s payout and future growth; T and VICI can remain cheap for a long time if the macro stays unchanged. The thesis breaks if 10Y yields fall sharply, if SNY pipeline data disappoints, or if telecom competition proves more than narrative risk.

Key Decisions for Investors

• Prefer long SNY over T on a 3-6 month horizon: SNY has the cleaner fundamental runway, while T is more of a rate-trade. Target a relative outperformance of 5-8% if healthcare holds up and telecom stays rangebound.
• Use T as a short/underweight only if Starlink mobile becomes commercially credible or if T loses pricing discipline; otherwise keep it as a watch item, not a conviction short.
• For income exposure, favor VICI only on rate pullbacks: it should benefit if real yields roll over, but cap downside by waiting for confirmation that casino tenant credit remains stable.
• If you want the cleanest macro expression, pair long VICI / short a broad REIT proxy (IYR) on signs of falling rates; VICI’s higher quality cash flow should outperform lower-yielding REITs in a risk-off rate rally.
• No immediate event-driven trade if yields stay elevated: defer entry until either 10Y moves materially lower or company-specific guidance/pipeline updates create a fresh catalyst.